Roche Polska Sp. z o.o. secures contract for Pharmaceutical products - Successive deliveries of Phesgo to the new B9FM drug program for SPZOZ Opole Oncology Center in Opole

Poland, Jan. 20 -- Poland based Roche Polska Sp. z o.o. has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu for Pharmaceutical products - Successive deliveries of Phesgo to the new B9FM drug program for SPZOZ Opole Oncology Center in Opole. The value of the contract is worth 316413040 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....